Open AccessA randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
Author(s) -
Colin Reisner,
Leonardo M. Fabbri,
Edward Kerwin,
Charles Fogarty,
Selwyn Spangenthal,
Klaus F. Rabe,
Gary T. Ferguson,
Fernando J. Martinez,
James F. Donohue,
Patrick Darken,
Elizabeth Rose,
Chad Orevillo,
Shan Strom,
Tracy Fischer,
Michael A. Golden,
Sarvajna Dwivedi
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/md2j-3z93
Subject(s) - metered dose inhaler , fixed dose combination , medicine , formoterol fumarate , glycopyrrolate , inhaler , formoterol , anesthesia , pharmacology , inhalation , asthma , atropine , budesonide